Virtu Financial LLC Galapagos Nv Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 19, 2021	SELL	$76.15 - $111.94 $163,037 - $239,663	-2,141 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$96.85 - $148.25 $207,355 - $317,403	2,141 New	2,141 $212,000
Q3 2020 Dec 11, 2020	SELL	$122.47 - $213.56 $544,379 - $949,274	-4,445 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$185.52 - $231.25 $656,184 - $817,931	-3,537 Reduced 44.31%	4,445 $877,000
Q3 2018 Nov 13, 2018	BUY	$90.63 - $120.22 $335,331 - $444,814	3,700 Added 86.41%	7,982 $897,000
Q1 2018 May 14, 2018	BUY	$94.51 - $120.23 $404,691 - $514,824	4,282 New	4,282 $427,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.77B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.